Caitlin Lynch
Papers
1
Total Citations
49
H-Index
1
About
Dr. Caitlin Lynch is a leading voice in the advancement of in vitro toxicology, with her work directly addressing the critical need to replace traditional, slow, and costly animal testing with high-throughput, human-relevant models. Her most cited paper, "High-Throughput Screening to Advance In Vitro Toxicology: Accomplishments, Challenges, and Future Directions" (2023, 49 citations), serves as a definitive roadmap for the field, synthesizing the progress made in using robotic screening and cell-based assays to rapidly predict chemical and drug toxicity. Dr. Lynch’s key contributions lie in identifying the bottlenecks—such as metabolic competence and complex tissue modeling—that must be overcome to make these methods truly predictive. By clearly articulating both the accomplishments and the remaining hurdles, her work has become an essential reference for researchers and regulators alike, helping to accelerate the shift toward safer, more efficient chemical testing. Her research is pivotal for reducing drug candidate failure rates and for managing the growing backlog of untested environmental chemicals, marking her as a key architect of the future of toxicological science.
Research Focus
Key Achievements
Top Papers
- 1